Home » Meda Announces Approval of Sublinox in Canada
Meda Announces Approval of Sublinox in Canada
Specialty pharmaceutical company Meda announced that the Canadian regulatory authority, Health Canada, has approved Sublinox for treatment of insomnia.
MENAFN
MENAFN
Upcoming Events
-
07May
-
14May
-
30May